A study of cannabidiol (GWP42003-P, CBD) in patients with tuberous sclerosis complex who experience seizures. A study of cannabidiol (GWP42003-P, CBD) in patients with tuberous sclerosis complex who experience ...
A double-blind, randomized, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P, CBD) as add-on therapy in patients with tuberous sclerosis complex who experience inadequately-controlled seizures A double-blind, randomized, placebo-controlled study to investigate the efficacy and safety of canna ...